Breaking: Pfizer settles Vyndamax (tafamidis) suit

It has been confirmed today that Pfizer settled with the final defendant, Hikma Pharmaceuticals.

Previous
Previous

Purdue Pharma Sentenced to $5.5 Billion as Court Clears Path for Opioid Settlement

Next
Next

Jazz Pharmaceuticals' Ziihera wins FDA priority review for first-line gastric cancer use